A generalizable brain extraction net (BEN) for multimodal MRI data from rodents, nonhuman primates, and humans
Abstract
Accurate brain tissue extraction on magnetic resonance imaging (MRI) data is crucial for analyzing brain structure and function. While several conventional tools have been optimized to handle human brain data, there have been no generalizable methods to extract brain tissues for multimodal MRI data from rodents, nonhuman primates, and humans. Therefore, developing a flexible and generalizable method for extracting whole brain tissue across species would allow researchers to analyze and compare experiment results more efficiently. Here, we propose a domain-adaptive and semi-supervised deep neural network, named the Brain Extraction Net (BEN), to extract brain tissues across species, MRI modalities, and MR scanners. We have evaluated BEN on 18 independent datasets, including 783 rodent MRI scans, 246 nonhuman primate MRI scans, and 4,601 human MRI scans, covering five species, four modalities, and six MR scanners with various magnetic field strengths. Compared to conventional toolboxes, the superiority of BEN is illustrated by its robustness, accuracy, and generalizability. Our proposed method not only provides a generalized solution for extracting brain tissue across species but also significantly improves the accuracy of atlas registration, thereby benefiting the downstream processing tasks. As a novel fully automated deep-learning method, BEN is designed as an open-source software to enable high-throughput processing of neuroimaging data across species in preclinical and clinical applications.
Data availability
All data (MRI data, source codes, pretrained weights and replicate demo notebooks for Figure 1-7) are included in the manuscript or available at https://github.com/yu02019/BEN.
-
A longitudinal MRI dataset of young adult C57BL6J mouse brainZenodo, doi:10.5281/zenodo.6844489.
-
CAMRI Rat Brain MRI DataOpenNeuro, doi:10.18112/openneuro.ds002870.v1.0.1.
-
CAMRI Mouse Brain MRI DataOpenNeuro, doi:10.18112/openneuro.ds002868.v1.0.1.
-
An Open Resource for Non-human Primate ImagingNeuron, doi:10.1016/j.neuron.2018.08.039.
-
The Adolescent Brain Cognitive Development (ABCD) study: Imaging acquisition across 21 sitesDevelopmental Cognitive Neuroscience, doi:10.1016/j.dcn.2018.03.001.
-
Multimodal population brain imaging in the UK Biobank prospective epidemiological studyNature Neuroscience, doi:10.1038/nn.4393.
Article and author information
Author details
Funding
National Natural Science Foundation of China (81873893,82171903,92043301)
- Xiao-Yong Zhang
Fudan University (the Office of Global Partnerships (Key Projects Development Fund))
- Xiao-Yong Zhang
Shanghai Municipal Science and Technology Major Project (No.2018SHZDZX01)
- Xiao-Yong Zhang
The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.
Ethics
Animal experimentation: Partial rodent MRI data collection were approved by the Animal Care and Use Committee of Fudan University, China. The rest rodent data (Rat-T2WI-9.4T and Rat-EPI-9.4T datasets) are publicly available (CARMI: https://openneuro.org/datasets/ds002870/versions/1.0.0). Marmoset MRI data collection were approved by the Animal Care and Use Committee of the Institute of Neuroscience, Chinese Academy of Sciences, China. Macaque MRI data are publicly available from the nonhuman PRIMatE Data Exchange (PRIME-DE) (https://fcon_1000.projects.nitrc.org/indi/indiPRIME.html).
Human subjects: The Zhangjiang International Brain Biobank (ZIB) protocols were approved by the Ethics Committee of Fudan University (AF/SC-03/20200722) and written informed consents were obtained from all volunteers. UK Biobank (UKB) and Adolescent Brain Cognitive Development (ABCD) are publicly available.
Copyright
© 2022, Yu et al.
This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.
Metrics
-
- 1,412
- views
-
- 192
- downloads
-
- 8
- citations
Views, downloads and citations are aggregated across all versions of this paper published by eLife.
Download links
Downloads (link to download the article as PDF)
Open citations (links to open the citations from this article in various online reference manager services)
Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)
Further reading
-
- Computational and Systems Biology
The force developed by actively lengthened muscle depends on different structures across different scales of lengthening. For small perturbations, the active response of muscle is well captured by a linear-time-invariant (LTI) system: a stiff spring in parallel with a light damper. The force response of muscle to longer stretches is better represented by a compliant spring that can fix its end when activated. Experimental work has shown that the stiffness and damping (impedance) of muscle in response to small perturbations is of fundamental importance to motor learning and mechanical stability, while the huge forces developed during long active stretches are critical for simulating and predicting injury. Outside of motor learning and injury, muscle is actively lengthened as a part of nearly all terrestrial locomotion. Despite the functional importance of impedance and active lengthening, no single muscle model has all these mechanical properties. In this work, we present the viscoelastic-crossbridge active-titin (VEXAT) model that can replicate the response of muscle to length changes great and small. To evaluate the VEXAT model, we compare its response to biological muscle by simulating experiments that measure the impedance of muscle, and the forces developed during long active stretches. In addition, we have also compared the responses of the VEXAT model to a popular Hill-type muscle model. The VEXAT model more accurately captures the impedance of biological muscle and its responses to long active stretches than a Hill-type model and can still reproduce the force-velocity and force-length relations of muscle. While the comparison between the VEXAT model and biological muscle is favorable, there are some phenomena that can be improved: the low frequency phase response of the model, and a mechanism to support passive force enhancement.
-
- Computational and Systems Biology
- Evolutionary Biology
There is growing interest in designing multidrug therapies that leverage tradeoffs to combat resistance. Tradeoffs are common in evolution and occur when, for example, resistance to one drug results in sensitivity to another. Major questions remain about the extent to which tradeoffs are reliable, specifically, whether the mutants that provide resistance to a given drug all suffer similar tradeoffs. This question is difficult because the drug-resistant mutants observed in the clinic, and even those evolved in controlled laboratory settings, are often biased towards those that provide large fitness benefits. Thus, the mutations (and mechanisms) that provide drug resistance may be more diverse than current data suggests. Here, we perform evolution experiments utilizing lineage-tracking to capture a fuller spectrum of mutations that give yeast cells a fitness advantage in fluconazole, a common antifungal drug. We then quantify fitness tradeoffs for each of 774 evolved mutants across 12 environments, finding these mutants group into classes with characteristically different tradeoffs. Their unique tradeoffs may imply that each group of mutants affects fitness through different underlying mechanisms. Some of the groupings we find are surprising. For example, we find some mutants that resist single drugs do not resist their combination, while others do. And some mutants to the same gene have different tradeoffs than others. These findings, on one hand, demonstrate the difficulty in relying on consistent or intuitive tradeoffs when designing multidrug treatments. On the other hand, by demonstrating that hundreds of adaptive mutations can be reduced to a few groups with characteristic tradeoffs, our findings may yet empower multidrug strategies that leverage tradeoffs to combat resistance. More generally speaking, by grouping mutants that likely affect fitness through similar underlying mechanisms, our work guides efforts to map the phenotypic effects of mutation.